AlloSource Launches AlloMend Duo Acellular Dermal Matrix, A Natural Solution For Non-Directional Implantation in Soft Tissue Reconstruction
May 26, 2023
May 26, 2023
CENTENNIAL, Colorado, May 26 -- AlloSource issued the following news release on May 25, 2023:
AlloSource(R), one of the largest nonprofit allograft providers in the U.S. creating innovative cellular and tissue products to help surgeons heal their patients, today announced the launch of AlloMend(R) Duo Acellular Dermal Matrix (ADM), a natural solution for soft tissue reconstruction.
AlloMend Duo ADM was created to help surgeons repair and reconstruct soft tissue defects . . .
AlloSource(R), one of the largest nonprofit allograft providers in the U.S. creating innovative cellular and tissue products to help surgeons heal their patients, today announced the launch of AlloMend(R) Duo Acellular Dermal Matrix (ADM), a natural solution for soft tissue reconstruction.
AlloMend Duo ADM was created to help surgeons repair and reconstruct soft tissue defects . . .